1. Home
  2. INGN vs IGA Comparison

INGN vs IGA Comparison

Compare INGN & IGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inogen Inc

INGN

Inogen Inc

N/A

Current Price

$6.27

Market Cap

173.2M

Sector

Health Care

ML Signal

N/A

Logo Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest

IGA

Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest

N/A

Current Price

$9.57

Market Cap

152.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
INGN
IGA
Founded
2001
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
173.2M
152.5M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
INGN
IGA
Price
$6.27
$9.57
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
327.6K
50.3K
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
8.93%
EPS Growth
43.42
N/A
EPS
N/A
N/A
Revenue
$348,668,000.00
N/A
Revenue This Year
$7.92
N/A
Revenue Next Year
$7.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.86
N/A
52 Week Low
$5.34
$8.43
52 Week High
$9.13
$10.12

Technical Indicators

Market Signals
Indicator
INGN
IGA
Relative Strength Index (RSI) 52.04 30.91
Support Level $5.67 $9.39
Resistance Level $7.12 $9.87
Average True Range (ATR) 0.42 0.09
MACD 0.03 -0.05
Stochastic Oscillator 61.92 11.12

Price Performance

Historical Comparison
INGN
IGA

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

About IGA Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest

Voya Global Advantage and Premium Opportunity Fund is a United States-based diversified, closed-end management investment company. The fund has two investment objectives. Its primary objective is to provide a high level of income, while the secondary objective is to seek capital appreciation. To achieve these objectives, the fund invests at least 80% of its managed assets in a portfolio of common stocks from various countries around the world, including the United States. Additionally, it uses an integrated derivatives strategies.

Share on Social Networks: